 TORONTO, Jan. 05, 2022 GLOBE NEWSWIRE -- Field Trip Health Ltd. TSX: FTRP, FTRP.WT, Nasdaq: FTRP Field Trip, a global leader in the development and delivery of psychedelic therapies, announced today that Field Trips Co-Founder and CEO, Joseph del Moral, and Chief Scientific Officer, Dr. Nathan Bryson, will participate in a virtual fireside chat at the H.C. Wainwright Bioconnect Virtual Conference taking place January 10-13, 2022. 